The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Association of Red Blood Cell Distribution Width With Mortality Risk in Hospitalized Adults With SARS-CoV-2 Infection
Open accessAbstract
Importance: Coronavirus disease 2019 (COVID-19) is an acute respiratory illness with a high rate of hospitalization and mortality. Biomarkers are urgently needed for patient risk stratification. Red blood cell distribution width (RDW), a component of complete blood counts that reflects cellular volume variation, has been shown to be associated with elevated risk for morbidity and mortality in a wide range of diseases. Objective: To investigate whether an association between mortality risk and elevated RDW at hospital admission and during hospitalization exists in patients with COVID-19. Design, Setting, and Participants: This cohort study included adults diagnosed with SARS-CoV-2 infection and admitted to 1 of 4 hospitals in the Boston, Massachusetts area (Massachusetts General Hospital, Brigham and Women's Hospital, North Shore Medical Center, and Newton-Wellesley Hospital) between March 4, 2020, and April 28, 2020. Main Outcomes and Measures: The main outcome was patient survival during hospitalization. Measures included RDW at admission and during hospitalization, with an elevated RDW defined as greater than 14.5%. Relative risk (RR) of mortality was estimated by dividing the mortality of those with an elevated RDW by the mortality of those without an elevated RDW. Mortality hazard ratios (HRs) and 95% CIs were estimated using a Cox proportional hazards model. Results: A total of 1641 patients were included in the study (mean [SD] age, 62[18] years; 886 men [54%]; 740 White individuals [45%] and 497 Hispanic individuals [30%]; 276 nonsurvivors [17%]). Elevated RDW (>14.5%) was associated with an increased mortality risk in patients of all ages. The RR for the entire cohort was 2.73, with a mortality rate of 11% in patients with normal RDW (1173) and 31% in those with an elevated RDW (468). The RR in patients younger than 50 years was 5.25 (normal RDW, 1% [n = 341]; elevated RDW, 8% [n = 65]); 2.90 in the 50- to 59-year age group (normal RDW, 8% [n = 256]; elevated RDW, 24% [n = 63]); 3.96 in the 60- to 69-year age group (normal RDW, 8% [n = 226]; elevated RDW, 30% [104]); 1.45 in the 70- to 79-year age group (normal RDW, 23% [n = 182]; elevated RDW, 33% [n = 113]); and 1.59 in those ≥80 years (normal RDW, 29% [n = 168]; elevated RDW, 46% [n = 123]). RDW was associated with mortality risk in Cox proportional hazards models adjusted for age, D-dimer (dimerized plasmin fragment D) level, absolute lymphocyte count, and common comorbidities such as diabetes and hypertension (hazard ratio of 1.09 per 0.5% RDW increase and 2.01 for an RDW >14.5% vs ≤14.5%; P < .001). Patients whose RDW increased during hospitalization had higher mortality compared with those whose RDW did not change; for those with normal RDW, mortality increased from 6% to 24%, and for those with an elevated RDW at admission, mortality increased from 22% to 40%. Conclusions and Relevance: Elevated RDW at the time of hospital admission and an increase in RDW during hospitalization were associated with increased mortality risk for patients with COVID-19 who received treatment at 4 hospitals in a large academic medical center network.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Grasselli, G., Zangrillo, A., Zanella, A., Antonelli, M., Cabrini, L., Castelli, A., Cereda, D., Coluccello, A., Foti, G., Fumagalli, R., et al. (2020) · JAMA · doi:10.1001/jama.2020.5394 · Cited by 5,469
COVID-19 and its implications for thrombosis and anticoagulation
Connors, J. M., & Levy, J. H. (2020) · Blood · doi:10.1182/blood.2020006000 · Cited by 2,369
Hospitalization and mortality among Black patients and White patients with Covid-19.
Price-Haywood, E. G., Burton, J., Fort, D., & Seoane, L. (2020) · New England Journal of Medicine · doi:10.1056/nejmsa2011686 · Cited by 1,660
Coronavirus disease 2019 case surveillance—United States, January 22–May 30, 2020.
Stokes, E. K., Zambrano, L. D., Anderson, K. N., Marder, E. P., Raz, K. M., El Burai Felix, S., Tie, Y., & Fullerton, K. E. (2020) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6924e2 · Cited by 1,538 · cited 1×
“001 Black/African American 223 (16) 58 (21) .”
Red blood cell distribution width: A simple parameter with multiple clinical applications
Salvagno, G. L., Sanchis-Gomar, F., Picanza, A., & Lippi, G. (2015) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2014.992064 · Cited by 1,236
Assessing differential impacts of COVID-19 on black communities
Millett, G. A., Jones, A. T., Benkeser, D., Baral, S., Mercer, L., Beyrer, C., Honermann, B., Lankiewicz, E., Mena, L., Crowley, J. S., et al. (2020) · Annals of Epidemiology · doi:10.1016/j.annepidem.2020.05.003 · Cited by 1,217
Red Cell Distribution Width as a Novel Prognostic Marker in Heart Failure
Felker, G. M., Allen, L. A., Pocock, S. J., Shaw, L. K., McMurray, J. J. V., Pfeffer, M. A., Swedberg, K., Wang, D., Yusuf, S., Michelson, E. L., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.067 · Cited by 947
Spiezia, L., Boscolo, A., Poletto, F., Cerruti, L., Tiberio, I., Campello, E., Navalesi, P., & Simioni, P. (2020) · Thrombosis and Haemostasis · doi:10.1055/s-0040-1710018 · Cited by 699
Red blood cell distribution width and the risk of death in middle-aged and older adults
Patel, K. V., Ferrucci, L., Ershler, W. B., Longo, D. L., & Guralnik, J. M. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.11 · Cited by 618
Red Blood Cell Distribution Width and Mortality Risk in a Community-Based Prospective Cohort
Perlstein, T. S., Weuve, J., Pfeffer, M. A., & Beckman, J. A. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.55 · Cited by 533
Gong, J., Ou, J., Qiu, X., Jie, Y., Chen, Y., Yuan, L., Cao, J., Tan, M., Xu, W., Zheng, F., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa443 · Cited by 513
Disparities in the Population at Risk of Severe Illness From COVID-19 by Race/Ethnicity and Income
Raifman, M. A., & Raifman, J. R. (2020) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2020.04.003 · Cited by 497
Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c
Cohen, R. M., Franco, R. S., Khera, P. K., Smith, E. P., Lindsell, C. J., Ciraolo, P. J., Palascak, M. B., & Joiner, C. H. (2008) · Blood · doi:10.1182/blood-2008-04-154112 · Cited by 478
Red Cell Distribution Width and Mortality in Older Adults: A Meta-analysis
Patel, K. V., Semba, R. D., Ferrucci, L., Newman, A. B., Fried, L. P., Wallace, R. B., Bandinelli, S., Phillips, C. S., Yu, B., Connelly, S., et al. (2010) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glp163 · Cited by 477
Wang, C., Deng, R., Gou, L., Fu, Z., Zhang, X., Shao, F., Wang, G., Fu, W., Xiao, J., Ding, X., et al. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-3391 · Cited by 219
Modulation of red blood cell population dynamics is a fundamental homeostatic response to disease
Patel, H. H., Patel, H. R., & Higgins, J. M. (2015) · American Journal of Hematology · doi:10.1002/ajh.23982 · Cited by 133
Self-citationAnderson, J. L., Ronnow, B. S., Horne, B. D., Carlquist, J. F., May, H. T., Bair, T. L., Jensen, K. R., & Muhlestein, J. B. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.08.015 · Cited by 128
Physiological and pathological population dynamics of circulating human red blood cells
Higgins, J. M., & Mahadevan, L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012747107 · Cited by 95
Self-citationKaragöz, E., Ülçay, A., Tanoğlu, A., Kara, M., Turhan, V., Erdem, H., Öncül, O., & Görenek, L. (2014) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000203 · Cited by 71
Muhlestein, J. B., LAPPE, D. L., Anderson, J. L., Muhlestein, J. B., Budge, D., May, H. T., Bennett, S. T., Bair, T. L., & Horne, B. D. (2016) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.12490 · Cited by 50
Yang, M., Weinberg, S. E., Zhao, L., Frink, A., Qi, C., Behdad, A., & Ji, P. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100475 · Cited by 48
Pan, Y., Ye, G., Zeng, X., Liu, G., Zeng, X., Jiang, X., Zhao, J., Chen, L., Guo, S., Deng, Q., et al. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.23 · Cited by 47
In Vivo Volume and Hemoglobin Dynamics of Human Red Blood Cells
Malka, R., Delgado, F. F., Manalis, S. R., & Higgins, J. M. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003839 · Cited by 44
Self-citationFreeman, J., Goldmann, D. A., & McGowan, J. E. (1988) · Clinical Infectious Diseases · doi:10.1093/clinids/10.6.1118 · Cited by 23
Topaz, G., Kitay‐Cohen, Y., Peled, L., Gharra, W., Kaminer, K., Eitan, M., Mahamid, L., & Shilo, L. (2017) · Journal of Critical Care · doi:10.1016/j.jcrc.2017.05.014 · Cited by 23
Developmental plasticity of red blood cell homeostasis
Golub, M. S., Hogrefe, C. E., Malka, R., & Higgins, J. M. (2014) · American Journal of Hematology · doi:10.1002/ajh.23666 · Cited by 22
Self-citationChaudhury, A., Miller, G., Eichner, D., & Higgins, J. M. (2019) · eLife · doi:10.7554/elife.48590 · Cited by 19
Self-citation
Cited by
COVID-19: Hemoglobin, Iron, and Hypoxia beyond Inflammation. A Narrative Review
Cavezzi, A., Troiani, E., & Corrao, S. (2020) · Clinics and Practice · doi:10.4081/cp.2020.1271 · Cited by 430
Mude, W., Oguoma, V. M., Nyanhanda, T., Mwanri, L., & Njue, C. (2021) · Journal of Global Health · doi:10.7189/jogh.11.05015 · Cited by 262
Metadata
- Authors
- Foy, B. H., Carlson, J. C. T., Reinertsen, E., Padros I. Valls, R., Pallares Lopez, R., Palanques-Tost, E., Mow, C., Westover, M. B., Aguirre, A. D., & Higgins, J. M.
- Venue
- JAMA Network Open
- Publisher
- American Medical Association (AMA)
- Published
- 2020-09-23
- Volume
- 3
- Issue
- 9
- Pages
- e2022058
- ISSN
- 2574-3805 (ISSN-L)
- OpenAlex
- W3087741580
- Cited by
- 319
- References
- 31
- FWCI
- 7.73
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.